Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMCC
2051
DELISTED
Old Market Capital Corp
OMCC
| $1.84M | ﹤0.01% |
368,751
-7,300
| -2% | -$36K |
|
2052
TETRA Technologies
TTI
$1.14B
| $1.84M | ﹤0.01% |
545,222
+194,946
| +56% | +$564K |
|
2053
VanEck Vietnam ETF
VNM
$491M
| $1.84M | ﹤0.01% |
138,600
-12,700
| -8% | -$159K |
|
2054
Fidelity National Financial
FNF
$13.9B
| $1.84M | ﹤0.01% |
51,099
-94,100
| -65% | -$3.28M |
|
2055
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
| $1.84M | ﹤0.01% |
43,500
-7,300
| -14% | -$316K |
|
2056
Schwab Fundamental US Large Company Index ETF
FNDX
$26.7B
| $1.84M | ﹤0.01% |
+95,700
| New | +$1.77M |
|
|
MDRX
2057
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.83M | ﹤0.01% |
145,365
+39,000
| +37% | +$474K |
|
2058
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.17B
| $1.83M | ﹤0.01% |
51,700
+36,600
| +242% | +$1.32M |
|
2059
German American Bancorp
GABC
$1.91B
| $1.83M | ﹤0.01% |
67,299
-35,149
| -34% | -$1.02M |
|
2060
Liberty Latin America Class A
LILA
$1.64B
| $1.82M | ﹤0.01% |
306,912
+42,601
| +16% | +$238K |
|
2061
Parke Bancorp
PKBK
$401M
| $1.82M | ﹤0.01% |
107,347
+1,100
| +1% | +$18.4K |
|
2062
Ceco Environmental
CECO
$3.85B
| $1.82M | ﹤0.01% |
136,183
+86,583
| +175% | +$1.08M |
|
2063
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
| $1.82M | ﹤0.01% |
+35,000
| New | +$1.77M |
|
|
BLUE
2064
DELISTED
bluebird bio
BLUE
| $1.81M | ﹤0.01% |
+27,510
| New | +$2.01M |
|
|
BCYC
2065
Bicycle Therapeutics
BCYC
$269M
| $1.81M | ﹤0.01% |
70,900
+9,000
| +15% | +$209K |
|
|
STRR
2066
Star Equity Holdings
STRR
$39.9M
| $1.81M | ﹤0.01% |
84,002
-9,963
| -11% | -$212K |
|
2067
Viridian Therapeutics
VRDN
$2.09B
| $1.81M | ﹤0.01% |
76,000
+40,200
| +112% | +$1.03M |
|
|
OPRA
2068
Opera Ltd
OPRA
$1.69B
| $1.8M | ﹤0.01% |
90,400
+33,400
| +59% | +$477K |
|
|
DRRX
2069
DELISTED
DURECT Corp
DRRX
| $1.79M | ﹤0.01% |
362,526
+87,860
| +32% | +$445K |
|
|
ONT
2070
Onterris Inc
ONT
$759M
| $1.79M | ﹤0.01% |
42,616
+27,316
| +179% | +$982K |
|
2071
Aspen Aerogels
ASPN
$384M
| $1.79M | ﹤0.01% |
227,400
+193,900
| +579% | +$1.35M |
|
2072
NatWest
NWG
$75.4B
| $1.79M | ﹤0.01% |
292,800
+163,400
| +126% | +$1.07M |
|
2073
eHealth
EHTH
$42.2M
| $1.79M | ﹤0.01% |
222,728
-168,600
| -43% | -$1.35M |
|
2074
Lindsay Corp
LNN
$1.13B
| $1.79M | ﹤0.01% |
15,000
+13,400
| +838% | +$1.66M |
|
|
VRTV
2075
DELISTED
VERITIV CORPORATION
VRTV
| $1.78M | ﹤0.01% |
14,207
-43,993
| -76% | -$5.15M |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.